The effectiveness of inhaled corticosteroids (ICS) in patients with chronic obstructive
pulmonary disease (COPD) remains controversial. Randomized controlled trials, meta …

PURPOSE: Although inhaled corticosteroids are commonly used to treat patients with
chronic obstructive pulmonary disease (COPD), their effect on clinical outcomes such as …

According to the current clinical practice guidelines for chronic obstructive pulmonary
disease (COPD), the addition of inhaled corticosteroids (ICS) to long-acting β 2 agonist …

Current guidelines limit regular use of inhaled corticosteroids (ICS) to a specific subgroup of
patients with chronic obstructive pulmonary disease (COPD) in whom the forced expiratory …

Background: Clinical studies suggest that inhaled corticosteroids reduce exacerbations and
improve health status in chronic obstructive pulmonary disease (COPD). However, their …

Background The use of inhaled corticosteroids (ICS) in combination with bronchodilators in
patients with COPD has been shown to decrease the rate of disease exacerbations and to …

Inhaled corticosteroids in chronic obstructive pulmonary dis... : Current Opinion in Pulmonary
Medicine Inhaled corticosteroids in chronic obstructive pulmonary disease: is there a long-term …

Background: Several clinical trials have evaluated the benefits associated with adding an
inhaled corticosteroid (ICS) to a long-acting bronchodilator in the treatment of severe or very …

Chronic obstructive pulmonary disease (COPD) is an increasingly important public health
problem. It remains one of the leading causes of disability in developed countries and is …

Importance of the field: Chronic obstructive pulmonary disease (COPD) is a disease
characterized by chronic airflow obstruction and a progressive lung function decline …